ProCE Banner Activity

Preventing Cytomegalovirus Infection in High-Risk Bone Marrow Transplant Patients

Multimedia
In this CME-certified interactive presentation, Kathleen Mullane, DO, PharmD, provides expert perspectives on optimal strategies for preventing and managing CMV infection in patients undergoing bone marrow transplantation.

Released: December 13, 2017

Expiration: December 12, 2018

No longer available for credit.

Share

Faculty

Kathleen Mullane

Kathleen Mullane, DO, PharmD

Professor of Medicine
Division of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Attending Physician
Immunocompromised Host Infectious Diseases Consult Service
University of Chicago Medicine
Chicago, Illinois

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck & Co., Inc.

Learning Objectives

  • Identify patients at high risk for CMV infection post bone marrow transplantation
  • Apply clinical practice guidelines and the results of recent clinical studies to prophylaxis for and treatment of CMV infection in the setting of bone marrow transplantation
  • Evaluate the impact of clinical studies of novel CMV prophylaxis and treatment strategies on current and future care of bone marrow transplantation patients

Faculty Disclosure

Primary Author

Kathleen Mullane, DO, PharmD

Professor of Medicine
Division of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Attending Physician
Immunocompromised Host Infectious Diseases Consult Service
University of Chicago Medicine
Chicago, Illinois

Kathleen Mullane, DO, PharmD, has disclosed that she has received consulting fees from Astellas, Chimerix, and Merck; fees for non-CME/CE activities from Astellas and Merck; and funds for research support from Actelion, AiCuris, Ansun, Astellas, Chimerix, Gilead Sciences, Glaxon, MedImmune, Merck, Rebiotix, Sage, Seres, Shire, Summit, and Scynexis.

Staff Disclosure

Staff

Gordon Kelley,

Clinical Editor
Clinical Care Options, LLC

Gordon Kelley has no real or apparent conflicts of interest to report.

Megan K. Murphy, PhD

Scientific Director

Megan Murphy, PhD, has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no real or apparent conflicts of interest to report.